RxDoctor Payments Data

Michael Tracy, MD

Orthopaedic Surgery · Yuma, AZNPI 1477733061

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,905 of the $45,386 with a category attached, or 65.9%. 6 manufacturers reported payments, led by Smith+Nephew at 51.3% of the total.

$45,386in general payments, 2019–2025

Across 75 payments — averaging $605.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$23K
  • Integra Lifesciences Corporation$20K
  • Arthrex$1K
  • Novus Surgical Solutions LLC$1K
  • Encore Medical, LP$106
  • Stryker$18

What the payments were for

  • Consulting fees$9,96022%
  • Speaking & faculty fees$29,90566%
  • Travel & lodging$4,52610%
  • Food & beverage$9942%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew36$23,303
Integra Lifesciences Corporation32$19,507
Arthrex3$1,335
Novus Surgical Solutions LLC2$1,117
Encore Medical, LP1$106
Stryker1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,386 in reported general payments places this provider in the 85th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$105,942
Medicare patients
285
Services billed
532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone137$1,057
Oxycodone Hcl97$604

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Yuma

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →